A proof-of-concept study to investigate the radiolabelling of human mesenchymal and hematopoietic stem cells with [ ⁸⁹ Zr]Zr-Df-Bz-NCS.

Autor: Kahts M; Pharmaceutical Sciences Department, School of Pharmacy, Sefako Makgatho Health Sciences University (SMU), Ga-Rankuwa, 0208, South Africa. maryke.kahts@smu.ac.za., Mellet J; Department of Medical Immunology, Institute for Cellular and Molecular Medicine, South African Medical Research Council (SAMRC) Extramural Unit for Stem Cell Research and Therapy, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa., Durandt C; Department of Medical Immunology, Institute for Cellular and Molecular Medicine, South African Medical Research Council (SAMRC) Extramural Unit for Stem Cell Research and Therapy, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa., Moodley K; Department of Medical Immunology, Institute for Cellular and Molecular Medicine, South African Medical Research Council (SAMRC) Extramural Unit for Stem Cell Research and Therapy, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa., Summers B; Pharmaceutical Sciences Department, School of Pharmacy, Sefako Makgatho Health Sciences University (SMU), Ga-Rankuwa, 0208, South Africa., Ebenhan T; Radiochemistry, South African Nuclear Energy Corporation, Pelindaba, Hartebeespoort, South Africa., Zeevaart JR; Radiochemistry, South African Nuclear Energy Corporation, Pelindaba, Hartebeespoort, South Africa.; Nuclear Medicine Research Infrastructure (NuMeRI) NPC, Pretoria, South Africa.; DST/NWU, Preclinical Drug Development Platform, North-West University, Potchefstroom, South Africa., Aras O; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Radiology Department, AMRIC Health, New York, NY, USA., Pepper MS; Department of Medical Immunology, Institute for Cellular and Molecular Medicine, South African Medical Research Council (SAMRC) Extramural Unit for Stem Cell Research and Therapy, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.

Publikováno v: EJNMMI radiopharmacy and chemistry [EJNMMI Radiopharm Chem] 2024 Nov 29; Vol. 9 (1), pp. 82. Date of Electronic Publication: 2024 Nov 29.

Evaluation of [ ⁶⁸ Ga]Ga-DOTA-AeK as a Potential Imaging Tool for PET Imaging of Cell Wall Synthesis in Bacterial Infections.

Autor: Koatale PC; Department of Nuclear Medicine, University of Pretoria, Pretoria 0001, South Africa.; Nuclear Medicine Research Infrastructure (NuMeRI), Steve Biko Academic Hospital, Pretoria 0001, South Africa., Welling MM; Department of Radiology, Interventional Molecular Imaging Laboratory, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands., Mdanda S; Department of Nuclear Medicine, University of Pretoria, Pretoria 0001, South Africa.; Nuclear Medicine Research Infrastructure (NuMeRI), Steve Biko Academic Hospital, Pretoria 0001, South Africa., Mdlophane A; Department of Nuclear Medicine, University of Pretoria, Pretoria 0001, South Africa.; Nuclear Medicine Research Infrastructure (NuMeRI), Steve Biko Academic Hospital, Pretoria 0001, South Africa., Takyi-Williams J; Therapeutics Systems Research Laboratories (TSRL), Inc., Ann Arbor, MI 48109, USA., Durandt C; Department of Medical Immunology, Institute for Cellular and Molecular Medicine, University of Pretoria, Pretoria 0001, South Africa.; South African Medical Research Council Extramural Unit for Stem Cell Research and Therapy, University of Pretoria, Pretoria 0001, South Africa., van den Bout I; Department of Physiology, University of Pretoria, Pretoria 0001, South Africa., Cleeren F; Department of Pharmacy and Pharmacological Sciences, Radiopharmaceutical Research, KU Leuven, 3000 Leuven, Belgium., Sathekge MM; Department of Nuclear Medicine, University of Pretoria, Pretoria 0001, South Africa.; Nuclear Medicine Research Infrastructure (NuMeRI), Steve Biko Academic Hospital, Pretoria 0001, South Africa., Ebenhan T; Department of Nuclear Medicine, University of Pretoria, Pretoria 0001, South Africa.; Nuclear Medicine Research Infrastructure (NuMeRI), Steve Biko Academic Hospital, Pretoria 0001, South Africa.

Publikováno v: Pharmaceuticals (Basel, Switzerland) [Pharmaceuticals (Basel)] 2024 Aug 31; Vol. 17 (9). Date of Electronic Publication: 2024 Aug 31.

Effect of 2-methoxyestradiol on mammary tumor initiation and progression.

Autor: Peta KT; Department of Immunology, Institute for Cellular and Molecular Medicine, South African Medical Research Council, Extramural Unit for Stem Cell Research and Therapy, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa., Durandt C; Department of Immunology, Institute for Cellular and Molecular Medicine, South African Medical Research Council, Extramural Unit for Stem Cell Research and Therapy, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa., van Heerden MB; Department of Oral and Maxillofacial Pathology, School of Dentistry, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa., Joubert AM; Department of Physiology, School of Medicine, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa., Pepper MS; Department of Immunology, Institute for Cellular and Molecular Medicine, South African Medical Research Council, Extramural Unit for Stem Cell Research and Therapy, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa., Ambele MA; Department of Immunology, Institute for Cellular and Molecular Medicine, South African Medical Research Council, Extramural Unit for Stem Cell Research and Therapy, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.; Department of Oral and Maxillofacial Pathology, School of Dentistry, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.

Publikováno v: Cancer reports (Hoboken, N.J.) [Cancer Rep (Hoboken)] 2024 Apr; Vol. 7 (4), pp. e2068.

Haematopoietic stem-cell transplantation in an HIV endemic area: time to consider donors exposed to or living with HIV.

Autor: Hendricks CL; Institute for Cellular and Molecular Medicine, Department of Immunology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa; SAMRC Extramural Unit for Stem Cell Research and Therapy, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa., Mellet J; Institute for Cellular and Molecular Medicine, Department of Immunology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa; SAMRC Extramural Unit for Stem Cell Research and Therapy, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa., Durandt C; Institute for Cellular and Molecular Medicine, Department of Immunology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa; SAMRC Extramural Unit for Stem Cell Research and Therapy, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa., Brittain D; Alberts Cellular Therapy, Netcare Pretoria East Hospital, Pretoria, South Africa., Pepper MS; Institute for Cellular and Molecular Medicine, Department of Immunology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa; SAMRC Extramural Unit for Stem Cell Research and Therapy, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa. Electronic address: michael.pepper@up.ac.za.

Publikováno v: The lancet. HIV [Lancet HIV] 2023 Nov; Vol. 10 (11), pp. e742-e749. Date of Electronic Publication: 2023 Oct 11.

Consequences of HIV infection in the bone marrow niche.

Autor: Herd CL; Institute for Cellular and Molecular Medicine, Department of Medical Immunology, South African Medical Research Council (SAMRC) Extramural Unit for Stem Cell Research and Therapy, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa., Mellet J; Institute for Cellular and Molecular Medicine, Department of Medical Immunology, South African Medical Research Council (SAMRC) Extramural Unit for Stem Cell Research and Therapy, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa., Mashingaidze T; Institute for Cellular and Molecular Medicine, Department of Medical Immunology, South African Medical Research Council (SAMRC) Extramural Unit for Stem Cell Research and Therapy, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa., Durandt C; Institute for Cellular and Molecular Medicine, Department of Medical Immunology, South African Medical Research Council (SAMRC) Extramural Unit for Stem Cell Research and Therapy, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa., Pepper MS; Institute for Cellular and Molecular Medicine, Department of Medical Immunology, South African Medical Research Council (SAMRC) Extramural Unit for Stem Cell Research and Therapy, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.

Publikováno v: Frontiers in immunology [Front Immunol] 2023 Jul 11; Vol. 14, pp. 1163012. Date of Electronic Publication: 2023 Jul 11 (Print Publication: 2023).